HK1201050A1 - Polypeptides and their use - Google Patents

Polypeptides and their use Download PDF

Info

Publication number
HK1201050A1
HK1201050A1 HK15101528.2A HK15101528A HK1201050A1 HK 1201050 A1 HK1201050 A1 HK 1201050A1 HK 15101528 A HK15101528 A HK 15101528A HK 1201050 A1 HK1201050 A1 HK 1201050A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
sequence
amino acids
product
malassezia spp
Prior art date
Application number
HK15101528.2A
Other languages
English (en)
Chinese (zh)
Inventor
‧奧尼爾
D‧奥尼尔
‧莫瑟爾
D‧莫瑟尔
‧斯圖爾特
C‧斯图尔特
Original Assignee
诺瓦生命科学有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 诺瓦生命科学有限公司 filed Critical 诺瓦生命科学有限公司
Publication of HK1201050A1 publication Critical patent/HK1201050A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
HK15101528.2A 2012-03-14 2013-03-14 Polypeptides and their use HK1201050A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1204457.4 2012-03-14
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US201261620833P 2012-04-05 2012-04-05
US61/620833 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
HK1201050A1 true HK1201050A1 (en) 2015-08-21

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101528.2A HK1201050A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Country Status (17)

Country Link
US (1) US20140155321A1 (enExample)
EP (1) EP2825261A1 (enExample)
JP (1) JP2015516943A (enExample)
KR (1) KR20140138940A (enExample)
CN (1) CN104428036A (enExample)
AU (1) AU2013234122A1 (enExample)
CA (1) CA2866837A1 (enExample)
CL (1) CL2014002397A1 (enExample)
GB (1) GB201204457D0 (enExample)
HK (1) HK1201050A1 (enExample)
IL (1) IL234646A0 (enExample)
MX (1) MX2014010996A (enExample)
NZ (1) NZ700467A (enExample)
RU (1) RU2014139857A (enExample)
SG (1) SG11201405539QA (enExample)
WO (1) WO2013136040A1 (enExample)
ZA (1) ZA201407276B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016160399A1 (en) * 2015-04-03 2016-10-06 Elc Management Llc Hair treatment compositions
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
JPWO2017047299A1 (ja) * 2015-09-15 2017-12-21 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007002057A (es) * 2004-08-18 2007-07-19 Novabiotics Ltd Peptidos antimicrobianos que comprenden un motivo que contiene arginina y/o lisina.
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
CA2708554C (en) * 2007-12-21 2014-04-22 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
AU2013234122A1 (en) 2014-10-16
ZA201407276B (en) 2015-06-24
NZ700467A (en) 2016-08-26
SG11201405539QA (en) 2014-10-30
KR20140138940A (ko) 2014-12-04
CA2866837A1 (en) 2013-09-19
MX2014010996A (es) 2014-10-13
RU2014139857A (ru) 2016-05-10
US20140155321A1 (en) 2014-06-05
GB201204457D0 (en) 2012-04-25
EP2825261A1 (en) 2015-01-21
CL2014002397A1 (es) 2015-02-27
CN104428036A (zh) 2015-03-18
WO2013136040A1 (en) 2013-09-19
IL234646A0 (en) 2014-11-30
JP2015516943A (ja) 2015-06-18

Similar Documents

Publication Publication Date Title
WO2012168430A3 (en) Polypeptides
MY171146A (en) Compositions of glp-1 peptides and preparation thereof
PH12015501620A1 (en) Pharmaceutical composition with improved bioavailability
WO2017009843A3 (en) Compositions, articles of manufacture and methods for treating cancer
IN2014KN01713A (enExample)
IN2014KN01716A (enExample)
IN2014KN01714A (enExample)
CA2818990C (en) Designed repeat proteins binding to serum albumin
MX2014001372A (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico.
HK1203357A1 (en) Fibroblast growth factor 21 proteins
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
WO2012158962A3 (en) Improved peptide pharmaceuticals
WO2012042224A8 (en) Pharmaceutical composition comprising deferasirox
WO2010085700A3 (en) Treatment for obesity
WO2008093060A3 (en) Peptides and their use
HK1202800A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
WO2017093810A3 (en) Composition for intraoral delivery of biologically active peptides and proteins
GB201118201D0 (en) Novel peptides
IN2014MN02236A (enExample)
WO2011156003A3 (en) Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
HK1210598A1 (en) Di-and tri-heteroaryl derivatives as inhibitors of protein aggregation
WO2016209978A3 (en) Thiol-ene based peptide stapling and uses thereof
NZ700467A (en) Treatments suitable for malassezia infections
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
WO2013021284A3 (en) Anti-il-6 vaccine composition